Elaine Jones V.
Director, GYRE THERAPEUTICS, INC.
Companies
- NextCure, Inc.Board member May 8, 2019 to now1
- CytomX Therapeutics, Inc.Board member Oct 7, 2015 to now2
- Gritstone bio, Inc.Board member Sep 13, 2019 to Apr 8, 20253
- IBERE PHARMACEUTICALSBoard member Feb 25, 2021 to Feb 25, 20214
- Mersana Therapeutics (United States)Board member Jun 27, 2017 to Jun 27, 20175
- SYNLOGIC, INC.Board member Sep 30, 2015 to Sep 30, 20156
- Neurogene Inc.Board member Mar 6, 2014 to Mar 6, 20147
- Flexion TherapeuticsBoard member Feb 11, 2014 to Feb 11, 20148
- GYRE THERAPEUTICS, INC.Board member Apr 11, 2006 to Feb 12, 20089
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CytomX Therapeutics, Inc. CTMX5,142 shares10$11.8K at $2.30Mar 29, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 29, 2023Bought 5,000 shares at $1.55 of CytomX Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNextCure, Inc., Board member
- 2
- 3SEC EDGARGritstone bio, Inc., Board member
- 4SEC EDGARIBERE PHARMACEUTICALS, Board member
- 5
- 6SEC EDGARSYNLOGIC, INC., Board member
- 7SEC EDGARNeurogene Inc., Board member
- 8SEC EDGARFlexion Therapeutics, Board member
- 9
- 10